Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Withdrawn 1Terminated 1Recruiting 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 5Gastrointestinal 4Tumor-Agnostic 1Thoracic 1Other 1Lymphoid 1Dermatologic 1Classical hematology 1CNS 1Breast 1

Conditions

Osteoarthritis 1Lymphoma, Follicular 1Back Pain 1

Interventions

Rituximab 702Cyclophosphamide 645Vincristine 353Doxorubicin 309Etoposide 305Cytarabine 271Filgrastim 250Prednisone 249Methotrexate 241fludarabine phosphate 231Dexamethasone 209fludarabine 184Peripheral Blood Stem Cell Transplantation 166Radiotherapy 161Granulocyte Colony-Stimulating Factor 145Lenalidomide 144Bendamustine Hydrochloride 142Bortezomib 127Melphalan 126ibrutinib 111Busulfan 111Mycophenolic Acid 108Whole-Body Irradiation 107Tacrolimus 96Cyclosporine 87Gemcitabine 82Ifosfamide 80Calcium Dobesilate 80Alemtuzumab 80Leucovorin 78

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Oxycodone × Lymphoid × Clear all
NCT00784810 2011-11-02

A Study to Compare Oxycodone/Naloxone Prolonged Release Against Codeine/Paracetamol in the Treatment of Moderate to Severe Chronic Low Back Pain or Pain Due to Osteoarthritis

Napp Pharmaceuticals Limited

Phase 4 Completed
247 enrolled 9 charts
Lymphoid

Back Pain, Lymphoma, Follicular, Osteoarthritis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡